Overcoming pharmacokinetic problems in the treatment of Parkinson's disease

Mov Disord. 1989:4 Suppl 1:S70-85. doi: 10.1002/mds.870040510.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / pharmacokinetics*
  • Brain / drug effects
  • Brain / metabolism*
  • Humans
  • Levodopa / pharmacokinetics
  • Parkinson Disease / blood*
  • Parkinson Disease / drug therapy
  • Receptors, Dopamine / drug effects

Substances

  • Antiparkinson Agents
  • Receptors, Dopamine
  • Levodopa